1. Sanghvi, Viraj R, Leibold, Josef, Mina, Marco, Hendrickson, Ronald C, Wendel, Hans-Guido. . The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase. In Cell, 178, 807-819.e21. doi:10.1016/j.cell.2019.07.031. https://pubmed.ncbi.nlm.nih.gov/31398338/
2. Alderawi, Amr, Caramori, Gaetano, Baker, Emma H, Dunmore, Simon, Kirkham, Paul. . FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease. In BMJ open respiratory research, 7, . doi:10.1136/bmjresp-2020-000714. https://pubmed.ncbi.nlm.nih.gov/33208304/
3. Delpierre, G, Veiga-da-Cunha, M, Vertommen, D, Buysschaert, M, Van Schaftingen, E. . Variability in erythrocyte fructosamine 3-kinase activity in humans correlates with polymorphisms in the FN3K gene and impacts on haemoglobin glycation at specific sites. In Diabetes & metabolism, 32, 31-9. doi:. https://pubmed.ncbi.nlm.nih.gov/16523184/
4. Caruso, Maria Gabriella, Notarnicola, Maria, Altomare, Donato Francesco, Misciagna, Giovanni. 2008. Gene expression of fructosamine 3 kinase in patients with colorectal cancer. In Oncology, 73, 72-5. doi:10.1159/000120631. https://pubmed.ncbi.nlm.nih.gov/18334852/
5. Notarnicola, M, Caruso, Maria G, Tutino, V, Altomare, D F, Misciagna, G. 2010. Reduced fructosamine-3-kinase activity and its mRNA in human distal colorectal carcinoma. In Genes & nutrition, 5, 257-62. doi:10.1007/s12263-009-0165-y. https://pubmed.ncbi.nlm.nih.gov/21052529/
智鼠故事 
